Sign up here to receive news updates via email.
-
August 14, 2024 |
Media, News and Updates, Press Releases
The Power of NAi – De-risking Clinical Trials
read more -
August 13, 2024 |
Media, News and Updates, Press Releases
The Power of NAi – Drug Repurposing
read more -
August 12, 2024 |
Media, News and Updates, Press Releases
The Power of NAi – Biomarker Identification
read more -
July 8, 2024 |
Media, News and Updates, Press Releases
BPGbio Appoints Esteemed Cancer Researcher Dr. Dipanjan Chowdhury to Scientific Advisory Board
read more -
June 20, 2024 |
Press Releases, Media, News and Updates, Uncategorized
BPGbio Sponsors Mitochondrial Medicine 2024 Conference
read moreBPGbio, Inc., a leading biology-first, AI-powered, clinical stage biopharma focused on mitochondrial biology and protein homeostasis, today announced its sponsorship and participation in the United Mitochondrial Disease Foundation’s Mitochondrial Medicine Conference taking place June 26-29, 2024 in Cleveland, Ohio.
-
June 3, 2024 |
Press Releases, Media, News and Updates
BPGbio Appoints Biopharma Industry Leader Scott Minick to Board of Directors
read moreBPGbio, Inc., a leading biology-first, AI-powered, clinical stage biopharma focused on mitochondrial biology and protein homeostasis, today announced that seasoned biotech leader and venture capital investor, Scott Minick, has been elected to its Board of Directors. Mr. Minick will advise the executive team in the company’s next phase of commercialization and partnering transactions using its NAi Interrogative Biology Platform.
